In SCF (Skp1/Cullin/F-box protein) ubiquitin ligases, substrate specificity is conferred by a diverse array of F-box proteins. Only in fully assembled SCF complexes, it is believed, can substrates bound to F-box proteins become ubiquitinated. Here we show that Fbx2, a brain-enriched F-box protein implicated in the ubiquitination of glycoproteins discarded from the endoplasmic reticulum, binds the co-chaperone/ubiquitin ligase CHIP (C terminus of Hsc-70-interacting protein) through a unique N-terminal PEST domain in Fbx2. CHIP facilitates the ubiquitination and degradation of Fbx2-bound glycoproteins, including unassembled NMDA receptor subunits. These findings indicate that CHIP acts with Fbx2 in a novel ubiquitination pathway that links CHIP to glycoprotein quality control in neurons. In addition, they expand the repertoire of pathways by which F-box proteins can regulate ubiquitination and suggest a new role for PEST domains as a protein interaction motif.
domain of CHIP and an N-terminal PEST domain of Fbx2, CHIP facilitates the ubiquitination and degradation of Fbx2-bound glycoproteins. This study highlights a novel mechanism of F-box protein-mediated ubiquitination that contributes to glycoprotein homeostasis.
EXPERIMENTAL PROCEDURES
Plasmids-Expression plasmids (pcDNA3) for rat Fbx2 cDNA encoding FLAG-tagged Fbx2-Full and ⌬P/⌬F were kindly provided by Y. Yoshida (Tokyo Metropolitan Institute of Medical Science) (6) . FLAG-Fbx2-⌬P (amino acids 53-297), FLAG-Fbx2-⌬FBA (amino acids 1-94), and FLAGFbx2-⌬F (amino acids 1-49 and 92-296) were generated by PCR, subcloned into pcDNA3 at the KpnI and EcoRI sites, and sequence-verified. All experiments were performed with rat Fbx2 cDNA, except Fig. 2 , which used human Fbx2 cDNA. Human FLAG-Skp2 was generated using PCR subcloning from the pGBT8-hSKP2 plasmid (kindly provided by Y. Xiong (20) ) using the primer pairs 5Ј-CGCCAAGCTTG-CCACCATGGACTACAAGGACGACGATGACAAGATC-CACAGGAAGCACCTCCAG-3Ј and 5Ј-CGAATTCTCAT-AGACAACTGGGCTTTTG-3Ј and inserted into the HindIII and EcoRI sites of pcDNA3. Note that FLAG tag was generated in PCR primer. Expression plasmids for CHIP (WT, K30A, D253N/R254G, ⌬TPR, and ⌬E4) were kindly provided by C. Patterson (University of North Carolina) (21) . Human FLAGtagged Fbx2 (NM_036300), Fbx6 (NP_060908), Fbx44 (NP_ 149438), Fbx27 (NP_680474), and Fbx17 (NP_949142) were cloned from cDNA libraries of brain, heart, and kidney into pFLAG-CMV-6b (Sigma). Human FLAG-P-Fbx6 was subcloned by PCR into pFLAG-CMV-6b using HindIII/EcoRI and contains amino acids 1-51 of human Fbx2 in frame with amino acids 1-293 of Fbx6. NR2A and GFP-CFTR-⌬F508 constructs were kindly provided by Johannes Hell (University of Iowa) and Michael Welsh (University of Iowa), respectively.
Cell Culture and Transfection-COS cells were grown in Delbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum (HyClone) and 1% penicillin/streptomycin (Invitrogen). PC12 cells were grown in RPMI medium 1640 (Invitrogen) supplemented with 10% horse serum (HS; HyClone), 5% fetal bovine serum, and 1% penicillin/streptomycin. All cells were maintained at 37°C with 5% CO 2 . Transfections were performed with Lipofectamine PLUS TM reagent (Invitrogen) according to the manufacturer's protocol. FBA-containing constructs ( Fig. 2) were transfected in 10-cm dishes with the following DNA concentration to achieve equal expression levels: Fbx2 (1.25 g), Fbx6, Fbx44, Fbx17, and Fbx27 (4 g each).
Immunofluorescence-Cells cultured on chamber slides were fixed with 4% paraformaldehyde in PBS for 15 min, washed with 0.05% Triton X-100 in PBS, and blocked with 5% normal goat serum in PBS. Primary antibodies for FLAGtagged Fbx2 proteins, NR2A, and CHIP were used at 1:200 in PBS, 0.05% Triton X-100 for 1 h at 37°C. Alexa Fluor 488 goat anti-mouse and Alexa Fluor 568 goat anti-rabbit secondary antibodies (Molecular Probes) were used at 1:200 for 1 h at 37°C. Nuclei were detected by staining with 4Ј,6-diamidino-2-phenylindole (5 g/ml) for 10 min. Fixed samples were observed with a Zeiss Axioplan fluorescence microscope. Digital images were collected on separate red, green, and blue fluorescence channels with a SPOT digital camera. Images were assembled in PHOTOSHOP 6.0 (Adobe Systems, Mountain View, CA).
In Vitro Ubiquitination-FLAG-Fbx2 proteins were precipitated from COS cells as described below and eluted from the matrix using FLAG peptide in wash buffer. Eluted Fbx2 and bound substrates, including overexpressed NR2A, were incubated at 30°C for 2 h in 50 l of reaction solution (50 mM Tris-HCl (pH 7.2), 120 mM NaCl, 5 mM MgCl 2 , 4 mM ATP, and 0.5 mM dithiothreitol) containing 1 g of recombinant CHIP, 0.2 g of each of the following E2s (GST-UbcH5a, GSTUbcH5b, GST-UbcH5c, His-UbcH6, and UbcH7; Boston Biochem), 8 g of GST-ubiquitin (Boston Biochem), 0.5 g of E1 (Boston Biochem). After incubation, SDS buffer was added, and proteins were resolved on 4 -15% SDS-PAGE.
Immunoprecipitation and Western Blot Analysis-24 h after transfection, cells were lysed for co-IP experiments with buffer A (50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, and 1% Triton X-100) plus protease inhibitors (PI; Sigma), and FLAGtagged Fbx2 proteins were precipitated with EZ view FLAG beads (Sigma) for 1 h at 4°C with rotation. Beads were washed four times with 1 ml of buffer A and eluted with SDS Laemmli buffer (50 mM Tris (pH 6.8), 100 mM dithiothreitol, 1% SDS, 0.1% bromphenol blue, 10% glycerol) minus dithiothreitol to avoid antibody light chain dissociation.
Fbx2 was precipitated from PC12 cells prepared in buffer A plus PI, using the TrueBlot Set (eBioscience). Lysates were precleared with 30 l of anti-rabbit IgG beads (eBioscience) for 15 min and spun at 14,000 rpm for 3 min. Precleared lysates were incubated with 15 l of anti-Fbx2 rabbit polyclonal antibody for 1 h at 4°C, and then 50 l of anti-IgG beads were added for 2 h. Beads were washed three times in buffer A plus PI. Proteins were eluted with SDS Laemmli buffer, boiled for 10 min, and resolved on 4 -15% SDS-PAGE (Bio-Rad).
For steady state level of glycoprotein substrates (NR2A and GFP-CFTR-⌬F508) cells were transfected and grown for 48 h, lysed in Laemmli buffer, boiled 10 min, sonicated, and resolved on SDS-PAGE.
Proteins were electrophoresed on 4 -15% polyacrylamide gels (Bio-Rad) and transblotted to polyvinylidene difluoride membranes. For detection of glycoproteins, membranes were blocked for 2 min in 2% Tween 20 in PBS, rinsed with PBS, and incubated with 5 g of peroxidase-conjugated concanavalin A (ConA) (Sigma) in 30 ml of 0.2% Tween 20 in Tris-buffered saline supplemented with 1 mM CaCl 2 and 1 mM MnCl 2 overnight. For antibody blotting, membranes were blocked in blocking buffer (5% nonfat powdered milk in 0.2% Tween 20 in TBS) for 20 min and incubated for 1 h with primary antibodies, followed by 1 h with peroxidase-conjugated secondary antibodies, both in blocking buffer. Bands were visualized using enhanced chemiluminescence (Amersham Biosciences).
The following antibodies were used for Western blot analysis: FLAG polyclonal (1:1000; Sigma catalog no. F7425), FLAG monoclonal (1:2000; Sigma catalog no. F4042), GFP monoclonal (1:1000; Roche Applied Science catalog no. 1-814-460), CHIP polyclonal (1:1000; EMD Bioscience catalog no. PC711), Tubulin monoclonal FL-76). Antibodies to NR2A (1:500), and NR2B (1:1000) were kindly provided by Johannes Hell (University of Iowa). A rabbit polyclonal antibody to Fbx2 was previously described (7) .
GST Pulldown Experiments-Fbx2-Full and CHIP-WT were subcloned into pGEX-6P1, using PCR and BamHI and XhoI restriction sites. Bacterial expression of GST proteins in BL21 (Invitrogen) was induced with 0.1 mM isopropyl 1-thio-␤-Dgalactopyranoside for 2 h at 37°C. Protein was isolated by sonication of bacteria in PBS plus PI and centrifugation. GST fusion proteins were purified using glutathione-Sepharose (Amersham Biosciences). CHIP was cleaved from GST using precission protease (Amersham Biosciences) for 3 h at 4°C. GST and GST-Fbx2 were isolated on glutathione columns and incubated with 4-month old brain lysates prepared in buffer A plus PI for 1 h at 4°C or with purified CHIP-WT for 3 h at 4°C. Mouse brain lysates were prepared as follows. Mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg) and xylazine (9 mg/kg) and perfused with PBS plus PI (Sigma); brains were frozen on dry ice and subsequently lysed in buffer A using a Dounce homogenizer at ϳ100 mg/ml. Bound proteins were washed twice with 1% Triton X-100 buffer (for lysates) or PBS (for CHIP) and eluted with reduced glutathione elution buffer (Amersham Biosciences). Bound proteins were analyzed on 4 -15% SDS-PAGE (Bio-Rad).
Pulse-chase Labeling-24 h after transfection, 60-mm dishes of COS cells were incubated in methionine-free medium for 15 min followed by pulse labeling with 0.15 mCi/ml [ 35 S]methionine for 30 min. After labeling, cells were quickly washed three times with normal medium, chased for the indicated times, washed two times with PBS, and then lysed in radioimmune precipitation buffer (150 mM NaCl, 50 mM Tris (pH 8.0), 1% Nonidet P-40, 0.5% deoxycholic acid, 0.1% SDS) plus PI buffer. GFP-tagged CFTR was precipitated with 5 g of GFP monoclonal antibody (Roche Applied Science) and EZ view protein A beads (Sigma). Proteins were eluted with SDS and resolved on 6% SDS-PAGE and processed for autoradiography.
Analysis of NR2A Glycosylation-24 h after transfection with NR2A expression plasmid, COS cells were treated with or without tunicamycin (5 g/ml) for 24 h prior to lysis in buffer A. Endoglycosidase H and peptide:N-glycanase (New England Biolabs) treatments of lysates were performed according to the manufacturer's protocol. Samples were then assessed by Western blot using anti-NR2A antibody.
Densitometry and Statistical Analysis-Western blot lane intensities for ConA and ubiquitin were quantified using Scion Image software. Equal lane volumes were analyzed for pixel density and subtracted from the background density. Fbx2 with vector was set arbitrarily to 100 in each independent experiment (n ϭ 3), and the percentage change was recorded. For NR2A experiments, band intensities were quantified using Image J software, subtracted from background, and normalized to tubulin intensity (n ϭ 3). Data are shown as the average Ϯ S.D. Student's t test was performed to determine significance at p Ͻ 0.005 (for ConA and ubiquitin) and p Ͻ 0.05 (for NR2A). Aggresomes were quantitated using Adobe Photoshop on two representative images (ϫ20 magnification) from four independent experiments. The number of pixels above the predetermined threshold intensity for aggresomes was recorded. 50 -100 cells were analyzed per image. Vector control was set arbitrarily to 100, and the average percentage reduction in total pixels was recorded Ϯ S.D. for four independent experiments. For pulse-chase experiments, quantification of GFP-CFTR-⌬F508 densitometry was performed using Image J software (NIH Image). Band intensity was subtracted from background and compared with time 0, which was set to 100%.
Cultured Cortical Neuron-CHIP knock-out mice have been previously described (21) and were maintained on a 129SvEv ϫ C57BL/6 mixed background. Individual embryonic day 16 In c, the full blot probed with CHIP antibody is shown; the upper bands on the blot, which are not present in the starting lysate, reflect nonspecific bands resulting from the IP step. e, recombinant GST-Fbx2 and control GST were incubated with recombinant CHIP, followed by glutathione pulldown assay and probing with the indicated antibodies.
embryos were plated on poly-L-lysine (Sigma)-coated dishes and maintained for 5 days in Neurobasal maintenance medium (Invitrogen) supplemented with 2% B27, 1% penicillin/streptomycin, and 2 mM glutamine. CHIP genotyping was performed using embryo tail DNA as previously described (21) . Neurons were cultured in vitro for 5 days and lysed directly in Laemmli buffer, boiled for 10 min, sonicated, and resolved on SDS-PAGE.
RESULTS
As a first step toward defining the mechanism of action of Fbx2, we confirmed that it binds N-linked glycoproteins in vivo. FLAGtagged Fbx2 constructs (Fig. 1a) were expressed into COS cells, and epitope-tagged Fbx2 and associated proteins were immunoprecipitated from lysates. Proteins coprecipitating with Fbx2 were probed on blots with ConA, a lectin that specifically recognizes high mannose N-linked glycoproteins. Fbx2 bound to a wide range of high mannose glycoproteins (supplemental Fig. S1a) , as expected based on previous work (6) . Whereas the N-terminal F-box and PEST domains of Fbx2 were dispensable for glycoprotein binding, a fully intact FBA domain was required (data not shown) (6) . As a comparative negative control, we tested glycoprotein binding to an unrelated F-box protein, Skp2 (S-phase kinaseassociated protein 2). Skp2 failed to precipitate high mannose glycoproteins as illustrated by the absence of ConA signal on blots (supplemental Fig. S1c ).
Because Fbx2 expression is highly enriched in the nervous system, we tested whether recombinant GST-Fbx2 could bind high mannose glycoproteins from mouse brain lysates. As shown in supplemental Fig. S1b , a subset of high mannose glycoproteins from brain coprecipitated with Fbx2, consistent with a direct interaction between Fbx2 and glycoproteins. Taken together, these results show that Fbx2 binds brain glycoproteins through its FBA domain, consistent with its predicted role in glycoprotein homeostasis.
CHIP, a U-box-containing ubiquitin ligase (19) , has also been linked to the turnover of glycoproteins (14) . Because CHIP is expressed in brain (15) and is known to modulate the activity of another ubiquitin ligase (22) , CHIP may cooperate with Fbx2 in glycoprotein destruction. CHIP and Fbx2 also display the same cellular distribution in cell lines (whether as endogenous or overexpressed proteins) and in neurons in vivo; both are expressed diffusely in the cytoplasm (data not shown). This colocalization suggests a potential role in ERAD of glycoproteins. To address this possibility, we assayed for a physical interaction between Fbx2 and FIGURE 2. FBA family of F-box proteins displays divergent binding to CHIP in a PEST domain-dependent manner. a, the five human F-box proteins comprising the FBA family. PEST (pink), F-box (yellow), and FBA (blue) domains, leader sequence (white), and FLAG (F) epitope (green) are indicated. b, N-terminal sequences of the FBA proteins, with the PESTfind scores for each N terminus indicated at the left. Predicted PEST sequences in Fbx2 and Fbx27 are overlined and underlined, respectively. PESTfind (available on the World Wide Web at www.at.embnet.org/embnet/tools/bio/PESTfind/) ranks potential PEST sequences with scores from Ϫ50 to ϩ50, 0 denoting a possible PEST sequence and ϩ5 or greater denoting a significant PEST sequence. Conserved, core Skp1-interacting residues in the F-box domain (24) are indicated by a dot. c, co-IP of CHIP with each FBA protein family member, co-expressed in COS cells. Only Fbx2 and Fbx27 show appreciable binding to CHIP. ConA binding to the same blot shows that FBA proteins also differ in their ability to bind glycoproteins. d and e, the PEST domain of Fbx2 is sufficient to confer CHIP binding. FLAG-tagged Fbx2, FLAG-Fbx6, and a chimeric protein containing the PEST domain (pink) of Fbx2 fused to Fbx6 (FLAG-P-Fbx6) were each co-expressed with CHIP in COS cells. After IP with anti-FLAG antibody, blots were probed with the indicated antibodies or ConA. CHIP co-immunoprecipitates with FLAG-P-Fbx6 but not FLAG-Fbx6. In a and d, amino acid lengths for each protein are shown to the right. In c and e, a minus sign designates empty vector.
CHIP. Indeed, endogenous CHIP coprecipitated with endogenous Fbx2 in PC12 neural cells (Fig. 1b) .
Next, we mapped the CHIP binding site on Fbx2. Deleting the predicted PEST domain of Fbx2 (Fbx2-⌬P), but not its F-box (Fbx2-⌬F) or FBA domains (Fbx2-⌬FBA), markedly reduced CHIP binding in transfected cells (Fig. 1, c and d ) . Thus, the PEST domain is necessary for Fbx2-CHIP interactions. To determine whether this interaction represented direct binding between CHIP and Fbx2, we performed glutathione pulldown assays with recombinant CHIP and GST-Fbx2 (Fig.  1e) . GST-Fbx2 consistently coprecipitated CHIP well above the background levels seen with negative control GST. Thus, the interaction between CHIP and Fbx2 is direct.
The binding of CHIP to Fbx2 suggested the intriguing possibility that related F-box proteins might also bind CHIP. Fbx2 is a member of a family of five FBA-containing F-box proteins (23) that share sequence homology, including core Skp1-interacting residues in the F-box (24) (Fig. 2, a and b) . Sequence analysis predicts that the N-terminal domains of two of the five FBA proteins, Fbx2 and Fbx27, fulfill criteria for strong and weak PEST domains, respectively (25, 26) (Fig. 2b) . PEST domains are hydrophilic stretches of 12 or more residues that contain at least one Pro or Glu and one Ser or Thr, lack positively charged residues, and are flanked by a Lys, Arg, or His. Thus, PEST domains are motifs rich in acidic amino acids but do not display conserved sequence alignments and do not constitute an independent structural fold. The other three FBA proteins do not have a predicted PEST motif. Interestingly, in tests of CHIP binding to all five FBA proteins, only the two PEST domain-containing FBA proteins, Fbx2 and Fbx27, were able to bind CHIP (Fig. 2c) . FBA proteins also differed in their degree of binding to high mannose glycoproteins, probably reflecting differences in core glycan binding residues within the FBA domains (11) . 3 One known function for PEST domains is to increase protein turnover (26) . Paradoxically, however, the PEST domain appears to stabilize Fbx2. Fbx2 is the only FBA protein we can express at very high levels in transfected cells (data not shown) and deleting the PEST domain actually reduces steady state levels of Fbx2 in cells (Fig. 1, c and d) .
The differential binding to CHIP of the FBA proteins allowed us to test whether the PEST domain was sufficient to confer binding to CHIP. We fused the PEST sequence from Fbx2 onto Fbx6 (Fig.  2d) , an FBA protein that normally does not bind CHIP. Placing the PEST domain next to the F-box in Fbx6 conferred CHIP binding to this fusion protein (Fig. 2e) , indicating that the PEST domain is sufficient to confer CHIP binding. Moreover, adding the PEST domain to Fbx6 caused it to be expressed at much higher levels, similar to the high levels seen with Fbx2. This supports the view that, in this particular instance, a PEST domain acts to stabilize rather than degrade the protein.
CHIP (Fig. 3a) is a bifunctional molecule, which, through its tetratricopeptide repeat (TPR) domain, binds heat shock proteins (16) and functions as a co-chaperone (15) and through its U-box domain (18) functions as an E3 ubiquitin ligase (19) or E4 chain elongation factor (27) . To map the Fbx2 binding site in CHIP, we coexpressed Fbx2 with CHIP containing point mutations that disrupt the TPR (K30A) or U-box (D253N/D254G) domains (21) . The K30A mutation in CHIP, which is known to abolish HSP70 binding (21) , eliminated binding by Fbx2 (Fig. 3b) , suggesting a similar binding mechanism for HSP70 and Fbx2. Competition experiments with recombinant HSP70, however, failed to disrupt Fbx2-CHIP binding (Fig. 3c) even when a great molar excess of HSP70 was added to immunopurified CHIP-Fbx2 complexes. CHIP is known to form a homodimer in which the two TPR domains are asymmetrically arranged (28) . This unique structural arrangement could allow both Fbx2 and HSP70 to bind different TPR domains and thus may account for our failure to see a competitive interaction with HSP70. Consistent with this possibility, some HSP70 co-precipitated with CHIP-Fbx2 complexes in this experiment, although we cannot conclude that this is specific binding, because the large amount of HSP70 could result in nonspecific binding. In contrast to K30A-CHIP, U-box mutant CHIP displayed even more robust binding to Fbx2 than did CHIP-WT (Fig. 3b) . Taken together, these results suggest that CHIP binds Fbx2 through its TPR domain in a manner that may be stabilized when its ubiquitin ligase domain is catalytically inactive.
The evidence for interactions between CHIP and Fbx2 led us to determine whether CHIP altered Fbx2-mediated processing of glycoproteins. When expressed with CHIP, Fbx2 coprecipitated significantly lower levels of ConA-detectable glycoproteins than did Fbx2 expressed alone (Fig. 4, a and b) . Importantly, this reduced glycoprotein load in the presence of CHIP was accompa- . CHIP binds to Fbx2 through its TPR domain. a, CHIP constructs used in this study. Point mutations that disrupt the TPR (K30A) and U-box (D253N/R254G) domains are shown as boldface, black lines. Deletion of the TPR and U-box domains have previously been described (17) . Amino acid residues are listed above. b, co-IP of FLAG-Fbx2 with WT-CHIP or mutant CHIP shows that the TPR domain mutation (K30A) abolishes, whereas the U-box mutation (D253N/R254G) enhances, CHIP binding to Fbx2. c, after co-precipitation of FLAG-Fbx2-Full and CHIP-WT, recombinant HSP70 or purified bovine serum albumin was added at 0 (Ϫ), 0.1, 1, and 10 g for 30 min. Western blot analysis after subsequent washing and elution of FLAG antibody matrix shows that HSP70 failed to disrupt CHIP binding to Fbx2.
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nied by increased ubiquitin signal in the coprecipitated proteins (Fig. 4, a and c) , suggesting that CHIP facilitates Fbx2-mediated ubiquitination of substrate glycoproteins. Consistent with this, coexpression of catalytically inactive, U-box mutant CHIP (D253N/R254G) led to an increase in glycoproteins bound by Fbx2 without a corresponding increase in ubiquitin signal of the bound proteins (Fig. 4, a-c) . In contrast, when expressed with the noninteracting, K30A mutant CHIP, Fbx2 did not show any change in coprecipitated glycoprotein or ubiquitin signal compared with Fbx2 expressed alone (Fig. 4, a-c) .
Next we determined the effect of the Fbx2-CHIP complex on physiologically relevant glycoproteins. Known glycoprotein substrates for Fbx2 include ␤1 integrin (6), SHPS-1 (12), CFTR-⌬F508 (6), and the NMDAR subunit NR1 (29) . First we examined CFTR-⌬F508, the most common mutant form of the cystic fibrosis disease protein CFTR. CFTR is a membrane glycoprotein that, when mutated, improperly folds in the ER and is eliminated by ERAD (30) . We chose to use GFP-tagged CFTR because it can readily be followed in transfected cells, where it is accurately processed, translocated into the ER, glycosylated, and degraded by ERAD. When CHIP-WT is co-expressed with Fbx2 in CFTR-expressing cells, there is a marked reduction in the steady state levels of GFP-tagged CFTR-⌬F508 assessed by immunofluorescence (Fig. 4d) and Western blot (Fig. 4e) , compared with when either Fbx2 or CHIP-WT is expressed alone. In contrast, GFP-CFTR-⌬F508 levels were minimally reduced in cells co-expressing CHIP-WT and Fbx2 that lacked its glycoprotein recognition domain (⌬FBA) or in cells co-expressing wild type Fbx2 and CHIP that lacked its ligase domain (⌬E4; Fig.  4, d and e) . These results indicate that both the glycan binding domain of Fbx2 and the ubiquitin ligase domain of CHIP are required for Fbx2-CHIP complexes to optimally reduce levels of GFP-CFTR-⌬F508. Arguing against the trivial, alternative explanation that these deletion mutants simply misfold is the fact that deleting the TPR or U-box domains of CHIP or the FBA domain of Fbx2 does not affect subcellular localization or cause either protein to form aggregates (data not shown).
Mutant proteins like CFTR-⌬F508 can accumulate in perinuclear aggresomes when clearance does not keep pace with production (31). Aggresomes of fluorescently tagged CFTR (or other misfolded proteins) are easily identified as intensely fluorescent inclusions that indent the nucleus and can be scored accurately under live cell fluorescence microscopy. Co-expression of full-length Fbx2 (Fbx2-Full) and CHIP-WT led to robust suppression of aggresome formation by GFP-CFTR-⌬F508 ( Fig. 4d ; reduced to 14 Ϯ 16% of control levels). In contrast, expression of Fbx2 or CHIP alone had a much more modest effect on aggresome formation (reduced to 63 Ϯ 20 and 56 Ϯ 14% of control levels, respectively). Consistent with the above results, aggresome suppression required an intact FBA domain in Fbx2 and intact TPR and U-box domains in CHIP (Fig. 4d) .
Pulse-chase analysis confirmed that GFP-CFTR-⌬F508 was more rapidly degraded in the presence of Fbx2 and CHIP-WT (Fig. 4f ) . Coexpression of Fbx2 and CHIP led to 73 and 92% of CFTR-⌬F508 being degraded at 1 and 3 h, respectively, compared with only 55 and 85% at 1 and 3 h with vector alone. In contrast, degradation of GFP-CFTR-⌬F508 was not accelerated in the presence of CHIP-K30A and Fbx2 (only 44 and 75% degraded at 1 and 3 h), presumably because CHIP-K30A fails to bind Fbx2 (Fig. 3b) . Thus, Fbx2 and CHIP act together to facilitate degradation of this well characterized ERAD substrate. Because CHIP-K30A does not bind Fbx2 yet still can function as a ubiquitin ligase (32), we suggest that the cooperative action of Fbx2 and CHIP to facilitate degradation of glycoprotein substrates requires direct interaction between Fbx2 and CHIP.
We then extended our analysis to Fbx2 substrate glycoproteins in the brain. Co-precipitation of endogenous Fbx2 from the brain confirmed its known interaction with the NR1 subunit of the NMDA receptor (29) (data not shown). We also observed an interaction with the NR2A subunit of the NMDAR in mouse brain (data not shown) and in transfected cells (supplemental Fig. S2 ). Ion channel subunits that fail to assemble into functional ion channel complexes in the ER are subject to ERAD (33) . If NR2A is expressed in the absence of its normal assembly partner NR1, it retains high mannose N-linked glycans (supplemental Fig. S3 ) and is recognized as a substrate by Fbx2. When co-expressed in NR2A-expressing cells, Fbx2-Full and CHIP-WT markedly decrease steady state levels of NR2A (Fig. 5, a and b) , presumably reflecting increased turnover. For complete suppression of NR2A levels, all functional domains of Fbx2 are required, including the F-box, PEST, and FBA domains (Fig. 5c ). In addition, both the TPR and U-box domains of CHIP are required (Fig. 5b) . Although Fbx2 minus its F-box still binds CHIP and NR2A and partially reduces NR2A levels (Fig. 5c) , full functional activity of the Fbx2-CHIP complex appears to correlate with the ability of Fbx2 to bind both Skp1 (through its F-box domain) and CHIP (through its PEST domain).
We also sought to determine if CHIP could directly ubiquitinate substrates bound by Fbx2. FLAG-Fbx2 was co-expressed with NR2A in transfected cells, immunoprecipitated from lysates, and subjected to in vitro ubiquitination with or without recombinant CHIP. In a PEST domain-dependent manner, CHIP ubiquitinated Fbx2-bound substrates, including co-expressed NR2A (Fig. 6a) ; the degree of NR2A ubiquitination was greatly increased when Fbx2 contained the PEST domain.
In contrast, using recombinant Fbx2 and CHIP we were unable to obtain in vitro ubiquitination of a model glycoprotein, RNase B (Fig. 6b ). Fbx2 has previously been shown to bind RNase B in vitro (6) but is unable to ubiquitinate RNase B in vitro as part of an SCF complex (34) . Because HSP70 in principle could modulate CHIP activity toward Fbx2 substrates, we tested RNaseB ubiquitination both in the presence and absence of HSP70 and an energy regenerating system. Neither condition led to Rnase B ubiquitination, although in the same reaction CHIP became autoubiquitinated and HSP70 became ubiquitinated, indicating robust ligase activity. This negative result with purified Fbx2 and CHIP suggests that CHIP-mediated ubiquitination of Fbx2-bound substrates may require other components provide by the cell, such as a SCF complex. Alternatively, Fbx2-CHIP complexes may act on only a subset of high mannose glycoproteins that do not include RNase B. Finally, we determined whether eliminating CHIP gene expression from neurons would lead to an accumulation of Fbx2 substrate glycoproteins. CHIP-null mice exhibit significant perinatal lethality and are susceptible to heat stress (21) . However, they are obtained at normal Mendelian ratios prior to birth at embryonic day 16 (21) . 4 Thus, we generated littermate-controlled, individually genotyped, embryonic (embryonic day 16) cortical neuronal cultures by mating mice heterozygous for CHIP deletion (21) . Levels of NR2B, the embryonic counterpart of NR2A, were significantly elevated in cultured CHIP Ϫ/Ϫ neurons compared with CHIP ϩ/ϩ or CHIP ϩ/Ϫ neurons (Fig. 7, a and b) . These in vivo results are consistent with CHIP functioning in the turnover of Fbx2-bound substrates.
DISCUSSION
Here we describe a direct interaction between the TPR domain of CHIP and the N-terminal PEST domain of Fbx2. Through this interaction, CHIP facilitates the ubiquitination and degradation of Fbx2-bound glycoproteins, including GFP-CFTR-⌬F508 and NR2A. Consistent with these findings, neurons deficient in CHIP have increased levels of NR2B, the embryonic counterpart of NR2A.
We conclude that CHIP functions with Fbx2 in substrate glycoprotein ubiquitination, extending the routes by which an F-box protein can mediate ubiquitination of proteins. Our data are most consistent with a cooperativity between Fbx2 and CHIP that depends upon their physical interaction and builds on existing functional properties of each individual protein.
For example, when coexpressed with Fbx2, CHIP containing a point mutation in the TPR domain that disrupts binding to Fbx2 failed to accelerate the turnover of a glycoprotein substrate. In addition, U-box domain mutations that abolish CHIP ligase activity increased CHIP and glycoprotein binding to Fbx2 but reduced the amount of co-precipitated ubiquitinated proteins, suggesting a dominant negative effect of this mutant. Finally, when coexpressed with CHIP, an Fbx2 protein lacking the Skp1-interacting F-box domain was inefficient at decreasing glycoprotein levels, although it still interacted with CHIP.
Based on these results, the simplest model of Fbx2-CHIP cooperativity is that, after conventional Fbx2-SCF complex formation, CHIP binds to the N-terminal PEST domain of Fbx2 in vitro ubiquitination assays were carried out with E1, E2s (Ubc5a, -5b, -5c, -6, and -7), GST-tagged ubiquitin, recombinant CHIP, and (in b only), an energyregenerating system (ERS). a, anti-FLAG matrix was used to purify Fbx2-bound substrates from lysates of COS cells co-expressing NR2A with Fbx2-Full or Fbx2-⌬P. When added to purified Fbx2-Full-bound substrates, CHIP increased ubiquitination (Ub n ) of NR2A over that seen when CHIP was added to Fbx2⌬P-bound substrates. NR2A was detected with anti-NR2A antibody. b, in vitro assay performed with recombinant Fbx2, recombinant CHIP, and RNaseB in the presence or absence of recombinant HSP70. The result shows CHIP-dependent ubiquitination of HSP70 and CHIP autoubiquitination but no ubiquitination of RNase B.
and facilitates the ubiquitination and degradation of neuronal N-linked glycoproteins (Fig. 7c) . In this scenario, CHIP could act as an E4 ubiquitin chain elongation factor in concert with the SCF complex. Alternatively, Fbx2 may act with CHIP in a nonconventional protein complex that is independent of SCF complex formation. Consistent with this possibility, we have been unable to detect Cullin-1 coprecipitation with Fbx2 even under the mildest lysis conditions, whereas we do with the four remaining FBA proteins. 5 It is also conceivable that CHIP could act with Fbx2 through both mechanisms; none of our findings precludes this possibility.
The recruitment of CHIP by a PEST domain is intriguing. PEST domains clearly promote degradation in certain protein contexts (26) . Our findings suggest, however, that in some instances, a PEST domain can serve instead as a protein-protein interaction domain that stabilizes the resident protein. Most PEST domains known to accelerate degradation reside near the C terminus of the degraded protein (26) , whereas the predicted PEST domains in Fbx2 are near the N terminus. CHIP binds to the PEST domain of Fbx2, suggesting that CHIP could function as a ubiquitin ligase in the degradation of Fbx2. However, we found no evidence that CHIP increases the turnover of Fbx2 in vitro, and levels of Fbx2 were unaffected in vivo by loss of CHIP. These data suggest that the PEST domain of Fbx2 serves as a protein-protein interaction domain, not as a degradation domain. Interestingly, the C-terminal motif (-EEVD) of heat shock proteins recognized by TPR domains (16) is highly acidic, similar to the abundance of glutamic acid residues in the PEST sequence of Fbx2. We hypothesize that the PEST domain of Fbx2 binds to CHIP with a mechanism similar to that of HSP70. As mentioned earlier, the structure of CHIP homodimers (28) makes it possible that CHIP could simultaneously bind Fbx2 and HSP70 through TPR domains.
Although our study is the first to link an F-box protein to an alternative ubiquitination pathway via CHIP, the human genome encodes nearly 70 F-box proteins (23) . Many of these F-box proteins possess large domains of unknown function located N-terminal to the F-box motif. Many of these domains, in turn, contain PEST-like sequences. These F-box proteins represent additional candidates for interaction with CHIP through PEST-like sequence domains.
CHIP and Fbx2 are both highly expressed in the brain, where glycoproteins serve many vital functions. The novel F-box protein-mediated ubiquitin pathway described here may have important implications for neuronal glycoprotein homeostasis and brain function. We show that NMDA receptor subunits are glycosylated and appear to be substrates for this Fbx2-CHIP complex. CHIP has been isolated from postsynaptic density fractions (35) , and Fbx2 colocalizes with postsynaptic proteins (29) , suggesting their functional involvement in synapses. Future in vivo studies in Fbx2-deficient and/or CHIP-deficient mice will be needed to explore how alterations in NMDA receptor levels affect brain and synaptic function. Identification of other glycoprotein substrates for the Fbx2-CHIP complex is currently under way.
